FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to solid fast-disintegrating dosage form of medication with antiparkinsonian action, which contains as active pharmaceutical ingredient memantine and/or memantine hydrochloride and cellulose II with the following ingredient ratio, wt %: memantine and/or memantine hydrochloride - 5-10, cellulose II - 90-95. Dosage form can represent pellet, created by method of direct pelletting.
EFFECT: obtaining fast-disintegrating in oral cavity dosage form, its distribution throughout oral cavity and delay of its transport to stomach, in order to provide medication delivery, not entering gastrointestinal tract and eliminating metabolism of medication in liver.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, AND ALSO A DOSAGE FORM BASED ON SPECIFIED PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, METHOD OF ITS OBTAINING AND USE OF DOSAGE FORM BASED ON PHARMACEUTICAL CEUTIC COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE | 2020 |
|
RU2810575C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| NEW PHARMACEUTICAL COMPOSITION OF TAMSULOZIN AND DUTASTERIDE | 2019 |
|
RU2795928C2 |
| SOLID MEDICINAL FORMULATION POSSESSING HISTAMINE-LIKE EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2308941C1 |
| SOLID MEDICINAL FORM OF MATRIX TYPE, WHICH HAS ANTI-INFLAMMATORY, ANALGESIC, FEBRIFUGAL ACTIVITY, WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2007 |
|
RU2354358C1 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| COMPOSITION OF SOLID QUICK-DISINTEGRATING TABLET | 2008 |
|
RU2472493C2 |
| ORAL PHARMACEUTICAL COMPOSITION MEMANTIN (OPTIONS) AND METHOD OF PREPARATION (OPTIONS) | 2007 |
|
RU2326660C1 |
| MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
| PHARMACEUTICAL COMPOSITION FOR DIABETES TREATMENT | 2007 |
|
RU2366421C2 |
